Morphine and ketamine treatment suppress the differentiation of T helper cells of patients with colorectal cancer in vitro

Hou,Min; Zhou,Naibao; Li,Hao; Wang,Baosheng; Wang,Xiuqin; Wang,Xingwu; Jiang,Tao; Wang,Kaiguo; Xue,Fushan

doi:10.3892/etm.2018.7035

Morphine and ketamine treatment suppress the differentiation of T helper cells of patients with colorectal cancer in vitro

Authors:
- Min Hou
- Naibao Zhou
- Hao Li
- Baosheng Wang
- Xiuqin Wang
- Xingwu Wang
- Tao Jiang
- Kaiguo Wang
- Fushan Xue
View Affiliations

Affiliations: Department of Anesthesiology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Science, Jinan, Shandong 250117, P.R. China, Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China
Published online on: November 29, 2018 https://doi.org/10.3892/etm.2018.7035
Pages: 935-942

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There have been conflicting reports regarding the effects of anesthetic and analgesic drugs on immune function in patients with cancer. The aim of the present study was to investigate changes to T helper (Th) cell populations in patients with colorectal cancer (CRC) and to assess the effects of morphine and ketamine on the differentiation of Th cells harvested from patients with CRC in vitro. Peripheral blood samples were extracted from 20 patients with CRC and 20 healthy participants. Peripheral blood mononuclear cells were isolated and incubated in a solution containing phorbol‑myristate‑acetate (PMA) and ionomycin in the presence or absence of morphine or various ketamine concentrations (25, 50, and 100 µM). Samples were analyzed 4 h later. Th1 and Th2 cells were significantly increased by PMA and ionomycin stimulation; however, Th1 cells and the Th1/Th2 ratio in PMA and ionomycin treatments were significantly decreased in the CRC group compared with the control group. Following incubation with PMA and ionomycin, morphine significantly decreased Th1 cells and the Th1/Th2 ratio in the CRC group. Ketamine did not significantly affect levels of Th1 or Th2 cells or the Th1/Th2 ratio at a concentration of 25 µM; however, a significant increase in the Th1/Th2 ratio was observed at a concentration of 50 µM and, at 100 µM, a significant decrease in Th1 and Th2 cells and an increase in the Th1/Th2 ratio were observed. The present study suggests that CRC may shift the balance of Th1/Th2 towards Th2 by inducing an immunological response, morphine is able to suppress the differentiation of Th cells and decreases the Th1/Th2 ratio, and ketamine may affect the differentiation of Th cells in a dose‑dependent manner.

View Figures

View References

1	Zhu J, Tan Z, Hollis-Hansen K, Zhang Y, Yu C and Li Y: Epidemiological trends in colorectal cancer in China: An ecological study. Dig Dis Sci. 62:235–243. 2017. View Article : Google Scholar : PubMed/NCBI
2	Marcus DA: Epidemiology of cancer pain. Curr Pain Headache Rep. 15:231–234. 2011. View Article : Google Scholar : PubMed/NCBI
3	Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM and Mamdani MM: Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med. 5:e13–e22. 2011.PubMed/NCBI
4	Hynninen MS, Cheng DC, Hossain I, Carroll J, Aumbhagavan SS, Yue R and Karski JM: Non-steroidal anti-inflammatory drugs in treatment of postoperative pain after cardiac surgery. Can J Anaesth. 47:1182–1187. 2000. View Article : Google Scholar : PubMed/NCBI
5	Lahtinen P, Kokki H, Hendolin H, Hakala T and Hynynen M: Propacetamol as adjunctive treatment for postoperative pain after cardiac surgery. Anesth Analg. 95:813–819. 2002. View Article : Google Scholar : PubMed/NCBI
6	Parikh B, Maliwad J and Shah VR: Preventive analgesia: Effect of small dose of ketamine on morphine requirement after renal surgery. J Anaesthesiol Clin Pharmacol. 27:485–488. 2011. View Article : Google Scholar : PubMed/NCBI
7	Kerr C, Holahan T and Milch R: The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: A case series. J Palliat Med. 14:1074–1077. 2011. View Article : Google Scholar : PubMed/NCBI
8	Umansky V: Immunosuppression in the tumor microenvironment: Where are we standing? Semin Cancer Biol. 22:273–274. 2012. View Article : Google Scholar : PubMed/NCBI
9	Draghiciu O, Nijman HW and Daemen T: From tumor immunosuppression to eradication: Targeting homing and activity of immune effector cells to tumors. Clin Dev Immunol. 2011:4390532011. View Article : Google Scholar : PubMed/NCBI
10	Munhoz RR and Postow MA: Recent advances in understanding antitumor immunity. F1000Res. 5:25452016. View Article : Google Scholar : PubMed/NCBI
11	Protti MP, De Monte L and Di Lullo G: Tumor antigen-specific CD4+T cells in cancer immunity: From antigen identification to tumor prognosis and development of therapeutic strategies. Tissue Antigens. 83:237–246. 2014. View Article : Google Scholar : PubMed/NCBI
12	Kurosawa S and Kato M: Anesthetics, immune cells, and immune responses. J Anesth. 22:263–277. 2008. View Article : Google Scholar : PubMed/NCBI
13	Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F and Galon J: Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 71:1263–1271. 2011. View Article : Google Scholar : PubMed/NCBI
14	Ubukata H, Motohashi G and Tabuchi T, Nagata H, Konishi S and Tabuchi T: Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol. 102:742–747. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hunter JD: Effects of anaesthesia on the human immune system. Hosp Med. 60:658–663. 1999. View Article : Google Scholar : PubMed/NCBI
16	Gao M, Jin W, Qian Y, Ji L, Feng G and Sun J: Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine. 56:458–465. 2011. View Article : Google Scholar : PubMed/NCBI
17	Gao M, Sun J, Jin W and Qian Y: Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3. Inflammation. 35:1069–1077. 2012. View Article : Google Scholar : PubMed/NCBI
18	Nicholl DS, Daniels HM, Ira Thabrew M, Grayer RJ, Simmonds MS and Hughes RD: In vitro studies on the immunomodulatory effects of extracts of Osbeckia aspera. J Ethnopharmacol. 78:39–44. 2001. View Article : Google Scholar : PubMed/NCBI
19	Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature. 383:787–793. 1996. View Article : Google Scholar : PubMed/NCBI
20	Adotévi O, Dosset M, Galaine J, Beziaud L, Godet Y and Borg C: Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine. Hum Vaccin Immunother. 9:1073–1077. 2013. View Article : Google Scholar : PubMed/NCBI
21	Wan YY: Multi-tasking of helper T cells. Immunology. 130:166–171. 2010. View Article : Google Scholar : PubMed/NCBI
22	Olson NC, Sallam R, Doyle MF, Tracy RP and Huber SA: T helper cell polarization in healthy people: Implications for cardiovascular disease. J Cardiovasc Transl Res. 6:772–786. 2013. View Article : Google Scholar : PubMed/NCBI
23	Evans CF, Galustian C, Bodman-Smith M, Dalgleish AG and Kumar D: The effect of colorectal cancer upon host peripheral immune cell function. Colorectal Dis. 12:561–569. 2010. View Article : Google Scholar : PubMed/NCBI
24	Kanazawa M, Yoshihara K, Abe H, Iwadate M, Watanabe K, Suzuki S, Endoh Y, Takita K, Sekikawa K, Takenoshita S, et al: Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res. 25:443–449. 2005.PubMed/NCBI
25	Tabata T, Hazama S, Yoshino S and Oka M: Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers. Am J Surg. 177:203–208. 1999. View Article : Google Scholar : PubMed/NCBI
26	Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP and Domino SE: Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg. 61:87–92. 1982. View Article : Google Scholar : PubMed/NCBI
27	Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, et al: Grading quality of evidence and strength of recommendations. BMJ. 328:14902004. View Article : Google Scholar : PubMed/NCBI
28	Hammoud HA, Aymard G, Lechat P, Boccheciampe N, Riou B and Aubrun F: Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundam Clin Pharmacol. 25:518–527. 2011. View Article : Google Scholar : PubMed/NCBI
29	Pala P, Hussell T and Openshaw PJ: Flow cytometric measurement of intracellular cytokines. J Immunol Methods. 243:107–124. 2000. View Article : Google Scholar : PubMed/NCBI
30	Whiteside TL: Cytokine assays. Biotechniques Suppl. 4-8(10): 12–15. 2002.
31	Freer G and Rindi L: Intracellular cytokine detection by fluorescence-activated flow cytometry: Basic principles and recent advances. Methods. 61:30–38. 2013. View Article : Google Scholar : PubMed/NCBI
32	Mackenzie NM and Pinder AC: Flow cytometry and its applications in veterinary medicine. Res Vet Sci. 42:131–139. 1987. View Article : Google Scholar : PubMed/NCBI
33	Foster B, Prussin C, Liu F, Whitmire JK and Whitton JL: Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol Chapter. 6:Unit 6.24. 2007. View Article : Google Scholar
34	Papadogiannakis EI, Kontos VI, Tamamidou M and Roumeliotou A: Determination of intracellular cytokines IFN-gamma and IL-4 in canine T lymphocytes by flow cytometry following whole-blood culture. Can J Vet Res. 73:137–143. 2009.PubMed/NCBI
35	Palma-Nicolás JP, Hernández-Pando R, Segura E, Ibarra-Sánchez MJ, Estrada-García I, Zentella-Dehesa A and López-Marín LM: Mycobacterial di-O-acyl trehalose inhibits Th-1 cytokine gene expression in murine cells by down-modulation of MAPK signaling. Immunobiology Immunobiology signaling. Immunobiology. 215:143–152. 2010. View Article : Google Scholar : PubMed/NCBI